| Piramal Critical Care Limited, London, Zweigniederlassung Rüschlikon - Rapifen, Injektions-/Infusionslösung | | 45204 | | 01 | | Rapifen | | Injektions-/Infusionslösung | | N01AH02 | | Alfentanil | | 12.08.1983 | | |
| | Composition | | alfentanilum 0.5 mg ut alfentanili hydrochloridum hydricum, natrii chloridum, aqua ad iniectabile, ad solutionem pro 1 ml corresp., natrium 3.54 mg. | | Packungsbestandteile | | Infusion solution | | | | | | Active Agent | Dose |
|---|
| Alfentanil | 0.5 mg/ml |
| | | | Inactive agents |
|---|
| Sodium Chloride |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 014 | 5 1 ampoule(s) à 2 ml | PR | PR | A+ | | Yes | | 049 | 50 1 ampoule(s) à 10 ml | PR | PR | A+ | | Yes |
|
|
